
    
      The proposed study examines the effect of oral naltrexone on self-injurious behavior (SIB) in
      adolescents and adults of normal intelligence. It is designed as a pilot study and will
      provide preliminary data for a larger scale clinical trial if found to be effective in the
      pilot study.
    
  